drugset / Trial / NCT03796026

A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea

NCT03796026

Phase 1 Completed 34 enrolled Janssen Research & Development, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect of multiple doses of seltorexant compared with placebo on respiration during sleep in adult participants with mild to moderate obstructive sleep apnea.

Timeline

Start
2019-01-04
Primary completion
2019-06-07
Completion
2019-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Seltorexant Small molecule 40 mg Oral